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An extensive family of endogenous C-type murine leukemia viruses (MuLV) 
are present in all somatic and germ line cells of the mouse (1).  Certain protein 
constituents of these retroviruses, most notably the surface glycoprotein gp70, 
can be expressed on lymphoid and epithelial cells, even in mouse strains such as 
129 where no complete virus has ever been isolated (2).  Furthermore, distinct 
gp70s  are expressed at  different sites (3-6),  implying that  gp70s  represent a 
multigene family of differentiation antigens (7). In strains such as AKR and HRS, 
this  seemingly compatible  relationship  between  host  and  virus  breaks  down, 
resulting in virus-induced leukemia at around 6-12  months of age (8, 9).  The 
onset of leukemia coincides with the appearance of leukemogenic recombinant 
viruses, derived via recombination between innocuous ecotropic and xenotropic 
retroviruses (10), primarily within the envelope gene encoding gp70 (11-13). 
In  the  present  study,  we  describe  an  antiserum  that  was  raised  against  a 
chemically synthesized peptide derived from the nucleotide sequence of a  Mo- 
loney MCF  virus  recently published  by Bosselman  et  al.  (13).  We  selected a 
region of the recombinant virus gp70 that was unique from the parental Moioney 
virus so as to provide a probe specific for the endogenous sequence involved in 
recombination. The results show that the antigenic determinants displayed by 
the above peptide are present specifically on an Mr 70,000  molecule produced 
by normal peanut agglutinin positive (PNA  ÷) thymocytes. 
Materials and Methods 
Synthetic Peptides.  We selected a  14-amino-acid-long  region of Moloney MCF virus 
gp70  which  resides  148  amino acids  from the  N-terminus of gp70,  as published  by 
Bosselman et al.  (13). The sequence in this  region is S-L-K-R-G-N-T-P-R-N-Q-G-P-C. 
This peptide was chemically synthesized as previously described (14) and conjugated to 
Keyhole  Limpet  Hemocyanin (KLH)  through  the  cysteine  residue as  described  for 
production of antisera (14). 
Antisera.  A broadly reactive goat antiserum to gp70 (G230, reference 15) was utilized 
as a positive control serum. R-47 (R206B08), a monoclonal antibody specific for Rauscher 
ecotropic virus, was also used as a check for specificity. 
Viruses.  Rauscher  (R-MuLV),  Moloney  (M-MuLV),  AKR  (AKR-MuLV),  Gross  (G- 
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MuLV), and Feline (FeLV) leukemia viruses were obtained from the Biological Carcino- 
genesis Branch of the National Institutes of Health. AKR 247 virus was grown in SC-1 
cells as previously described (10). Cultures of pure ecotropic R-MuLV and Rauscher-MCF 
were the generous gift of Dr. M. Vogt of the Salk Institute. 
Mice.  Mice were obtained from the breeding colony at Scripps  Clinic and Research 
Foundation, except for 129Glx- and 129 strains, which were obtained from Dr. T. Boyse 
of the memorial Sloan-Kettering Cancer Center. 
Prepa ration of Cell Extracts.  Mice were sacrificed and tissues were immediately removed 
and macerated in phosphate-buffered saline (PBS) containing 2.0 mM phenylmethylsul- 
fonyl fluoride (PMSF,  Sigma Chemical Co., St.  Louis, MO)  at 4°C.  Single cells were 
suspended, washed once, then extracted in PBS-PMSF  containing 1.0%  Nonidet P-40 
(NP40, Sigma). After 15 min at room temperature, the extract was filtered (0.45 #m) and 
stored at -20 °  C. Peanut agglutinin positive and negative cells were prepared as described 
(16) and treated as above for analysis. 
Western Blot Analyses.  Protein constituents of each tissue  sample were separated by 
SDS-PAGE as previously described (17), then electrophoretically blotted onto nitrocellu- 
lose  paper  (18).  Protein  bands  were  stained  with  0.01%  amido  black  stain  in  45% 
methanol/10% acetic acid to ensure transfer was adequate. The blots were then blocked 
and antibody labeled using a  modification of standard procedures.  Briefly, blots were 
exposed to a solution, designated BLOTTO, which contained 5% nonfat dry milk in PBS 
(pH 7.4) containing 0.01% Antifoam A emulsion (Sigma) and 0.001% merthiolate. The 
blots were allowed to block for 2-16  h  at 4°C,  then incubated with antibody in the 
presence of BLOTTO for 3 h. The blots were then washed three times in BLOTTO and 
incubated for 1 h at room temperature with 125I-staphylococcus protein A at a concentra- 
tion of 1 ×  106 cpm per gel lane. They were then washed extensively as above, rinsed 
with water, dried, and subjected to autoradiography. Alternatively, blots were developed 
using a peroxidase staining technique described elsewhere (18). 
Results 
The results of Western blot analyses using anti-peptide 81 antibody vs. several 
virus preparations are shown in Fig. 1 A. Reactivity was observed with AKR-247 
(lane 3), with the lower of two gp70 components of Gross virus (lane 5) and with 
preparations of Moloney virus (lane I) and Rauscher virus (lane 4). No reactivity 
was observed with AKR-MuLV gp70 (lane 2) or the predominant gp70 band of 
Gross virus (lane 5)  which reacted strongly with G230  heteroserum  (Fig.  1 B, 
lane 5).  All  the  virus  preparations  possessed  gp70s  strongly reactive  with the 
broadly reactive goat anti-gp70  antiserum (Fig.  1B).  Peroxidase staining of R- 
MuLV after treatment with G230 (Fig.  1 C, lane 1) resolved two reactive bands 
at approximately Mr  70,000.  Successive staining of one blot with anti-81  sera 
(Fig.  1 C, lane 2), followed by reaction with R47 monoclonal antibody (Fig.  1 C, 
lane 3) demonstrated that only the lower band was reactive with anti-81, while 
only the  upper  band  was reactive  with the ecotropic specific monoclonal.  We 
conclude the  RLV  Lot JLS/V9  is  contaminated with a  Rauscher recombinant 
virus whose gp70  runs  slightly lower  than ecotropic  gp70,  a  characteristic  of 
MCF-type viruses. Additional confirmation of the nonreactivity of anti-81  with 
ecotropic R-MuLV was obtained using a  known pure ecotropic R-MuLV (Fig. 
1 C, lanes 4 and 5).  Extracts of SC-1  cells infected with this virus were positive 
with the goat anti-gp70 heteroserum (lane 4), but did not react with anti-81 (lane 
5). 
Treatment of 81-TAg with a new endoglycosidase, Endo F (19), which removes 
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FIGURE  1.  Reactivity of anti-peptide 81  antiserum with retrovirus preparations. Shown in 
panels A and B are Western blots of the following virus preparations: Moloney (M-MuLV) 
(lane 1), AKR-MuLV, (lane 2), AKR-247 (lane 3),  Rauscher (R-MuLV) (lane 4), and Gross 
(G-MuLV) (lane 5). Panel A shows reactivity with anti-peptide 81 antiserum; panel B, reactivity 
with G230, a broadly reactive anti-gp70 heteroserum. Panel C, lane 1: peroxidase stained blot 
of R-MuLV versus G230, demonstrating the presence of two components not resolved using 
the  I-staphylococcal protein A technique. Lane 2 shows the reactivity of an identical blot 
with anti-81 peptide (125I staphylococcal protein A  labeled) and lane 3 shows the same blot 
labeled with  R47,  a  monoclonal antibody specific  for  ecotropic  R-MuLV.  Lanes 4  and 5 
contain a  separate preparation of pure ecotropic R-MuLV demonstrating, respectively, the 
reactivity with G230 and lack of reactivity with anti-81 peptide. FIGURE  2  Reactivity of anti- 
81  peptide antiserum with mouse tissues.  Western blots of NP-40 extracts of the following 
tissues from a 2-month old NZB mouse are shown: testes (lane 1), genital tract (lane 2), bone 
marrow (lane 3), spleen (lane 4), thymus (lane 5), and brain (lane 6). Panel A, amido black 
stain of the preparations; panel B, reactivity of anti-81 peptide; panel C, reactivity with G230 
heteroserum. 
49,000  (not shown) comparable  to viral gp70s (19). 
We next evaluated  the reactivity  of anti-81  with detergent  extracts  of normal 
NZB mouse tissues.  As can be seen on Fig.  2A, by amido black stain, a complex 
pattern  of proteins was transferred  to nitrocellulose  from each tissue,  including 
testes  (lane  1),  genital  tract  (lane  2),  bone  marrow  (lane  3),  spleen  (lane  4), 
thymus (lane 5), and brain (lane 6).  Reactivity  with anti-81  antiserum (Fig.  2B), 
however,  was  very  discrete.  Most  notably,  Mr  70,000  bands  were  detected  in 
thymus (lane 5) and brain (lane 6) and a  low molecular  weight component  was 
also recognized in testes (lane  1). Brain also contains a reactive band at about Mr 
150,000.  Most  significant  was the  lack  of reactivity  in  bone  marrow  or  spleen 
(lanes  3  and  4),  although  both  tissues  contained  multiple  components  strongly 
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FIGURE 3.  Expression of 81-TAg in thymus extracts. Thymus extracts of 1-3-mo-old male 
mice of the following strains are shown on panel A: 129Gjx-/BoyScr (lane 1),  129/J (lane 2), 
HRS/J-hr/hr (lane 3), HRS/J-hr/+ (lane 4), C57BL/6J (lane 5) and AKR/J (lane 6).  Lane 7 
contains AKR/J spleen extract. Panel B, anti-81-TAg reactivity with extracts from 18-mo-old 
(lane 1) and 2-too-old (lane 2) AKR mice. Lanes 3 and 4, anti-81-TAg reactivity obtained with 
2 month AKR thymocytes negative (lane 3) and positive (lane 4) for reactivity with peanut 
agglutinin (PNA). Lanes 5 and 6, reactivity with G230 heteroserum against PNA- and PNA  + 
thymocytes, respectively. Lane 7, extract from a spontaneous AKR/J thymic leukemia indicat- 
ing the positive reactivity of this tissue with anti-81 TAg. 
For  the  remainder of the  studies reported here,  we chose to  focus on  the 
thymus antigen, which we have termed 81-TAg. Fig. 3A, lanes 1-6 shows that 
81-TAg is expressed in thymus tissues of all  1-3  mo-old mouse strains tested 
including 129Gix-/BoyScr,  129/J, HRS/J (hr/hr),  HRS/J (hr/+),  C57BL/6J and 
AKR/J,  respectively. Lane 7 contains AKR/J spleen as a  negative control. We 
next evaluated the expression of 81-TAg in thymus tissues of 18-mo-old mice, 
at which point thymus regression had occurred. Thymocyte extracts from pairs 
of 18-mo-old and  2-mo-old AKR/J,  HRS/J  (hr/hr),  and C57BL/6J  mice were 
tested by  Western  blotting as  above.  Identical results  were obtained with all 
mouse strains. Results with AKR thymocytes are shown in Fig. 3B, lanes 1 and 
2.  81-TAg is not expressed in the lymphoid cells of the older thymus (lane I), 
but is expressed by  thymocytes of 2-mo-old mice (lane  2).  Thymocytes were 
further  subdivided by  agglutination with  peanut agglutinin and  subjected  to 
Western blot analysis with anti-81-TAg (Fig.  3b, lanes 3 and 4) or G230  (Fig. 
3 b, lanes 5 and 6). PNA-negative thymocytes were negative for 81-TAg (lane 3) 
and PNA-positive thymocytes were positive (lane 4).  Both PNA-negative (lane 
5) and PNA-positive (lane 6) thymocytes were, however, positive for gp70, when 
reacted  with  G230  heteroserum.  Finally,  we  examined  spontaneous  thymic 
leukemias from AKR/J  mice.  Fig.  3B,  lane  7 is a  Western blot of one AKR 
tumor showing that antigens related to 81-TAg appear in the transformed cells. 
All spontaneous AKR tumors examined expressed 81-TAg related molecules. 
Discussion 
In this report, we demonstrated the presence of an Mr 70,000 antigen (81- 
TAg)  in  PNA  +  thymocytes,  which  is  related  to  the  endogenous retrovirus 
involved in MCF-type recombination. 81-TAg is a glycosylated protein present 
in 2-3-too-old thymuses of all mouse strains tested, but not detectable in spleen, 
bone marrow, or lymphoid cells isolated from 18-mo-old thymuses. The results JOHNSON AND  ELDER  BRIEF  DEFINITIVE REPORT  1755 
indicate that this gp70 is not the same as the G~x differentiation antigen (7), since 
81-TAg was expressed equally by both G~x÷ and Gix- mouse strains as well as all 
other strains tested. 
Since the MCF virus from which the sequence for the peptide was taken causes 
a thymic leukemia (13), the expression of 81-TAg on thymocytes is particularly 
relevant. The restriction of 81-TAg expression to PNA  + thymocytes provides an 
interesting relationship to leukemic transformation. Certainly, if recombination 
resulted in constitutive expression of a  differentiation antigen involved in cell 
maturation, it might lead to neoplastic transformation. Whether 81-TAg qualifies 
as such an antigen is a point of continued research. 
Summary 
We prepared an antiserum to a  14-amino-acid-long synthetic peptide derived 
from the published nucleotide sequence of a Moloney virus-derived MCF recom- 
binant  virus.  This  peptide  is  not  found in  the  parental  Moloney virus  gp70 
sequence or in other ecotropic viruses so far sequenced. When several tissues of 
the mouse were examined by Western blot analysis for related molecules, we 
found that thymocytes from 2-3-mo-oid mice, but not splenic T  cells or bone 
marrow  cell  extracts  reacted  with this  probe.  We  found that  the M~  70,000 
thymic glycoprotein recognized  by  the  anti-peptide  antiserum  (81-TAg)  was 
present at equivalent levels on peanut agglutinin positive thymocytes in all mouse 
strains tested. These results indicate that 81-TAg is a differentiation antigen that 
is related to the substituted portion of an MCF retrovirus. 
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